SonoSite (NASDAQ: SONO) develops, manufactures and distributes hand-carried ultrasound systems for use in various medical specialties and in a range of clinical settings. The firm's devices range in size from small handheld units to laptop-sized systems and allow for point of care analyses where larger, cart-based machines may be too cumbersome. SonoSite systems support work in anesthesia, cardiology, critical and acute care, emergency medicine, OB/Gyn, radiology and surgery. Products are sold through direct sales representatives, third-party distributors and strategic alliances.

The company pleased investors earlier in the week, when it guided Q1 revenues to $52 million and said the company would make a profit. Wall Street had been looking for sales of $49.95 million and a deficit of a penny per share. In discussing the favorable view, the CEO particularly noted growth on the international side.

SonoSite (NASDAQ: SONO) develops, manufactures and distributes hand-carried ultrasound systems for use in various medical specialties and clinical settings. The firm's devices range in size from small handheld units to laptop-sized systems and allow for point of care analyses where larger, cart-based machines may be too cumbersome. SonoSite systems support work in anesthesia, cardiology, critical and acute care, emergency medicine, OB/Gyn, radiology and surgery. Products are sold through direct sales representatives, third-party distributors and strategic alliances.

The company pleased investors earlier in the week, when it guided Q4 revenues to $65 million and FY07 revenues to $205 million. The Street had been looking for $62.80 million and $203.3 million, respectively. In discussing the solid numbers, the CEO noted positive market responses to five recent product launches.